Login / Signup

Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes.

Brendon L NeuenScott D Solomon
Published in: Journal of the American College of Cardiology (2024)
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • metabolic syndrome
  • skeletal muscle